Literature DB >> 8239576

Treatment of Q fever.

D Raoult1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8239576      PMCID： PMC188061          DOI： 10.1128/AAC.37.9.1733

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  41 in total

1.  Failure of rifampicin and co-trimoxazole in Q fever endocarditis.

Authors:  N I Subramanya; J S Wright; M A Khan
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

2.  Q fever endocarditis of porcine xenograft valves.

Authors:  P J Ross; J JacobsoJn; J R Muir
Journal:  Am Heart J       Date:  1983-01       Impact factor: 4.749

3.  Q fever: a study of 111 consecutive cases.

Authors:  D W Spelman
Journal:  Med J Aust       Date:  1982-06-26       Impact factor: 7.738

4.  Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii.

Authors:  T Hackstadt; J C Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

5.  Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations.

Authors:  T F McCaul; J C Williams
Journal:  J Bacteriol       Date:  1981-09       Impact factor: 3.490

6.  [Clinical aspects observed during an epidemic of 415 cases of Q fever].

Authors:  G Dupuis; O Péter; D Pedroni; J Petite
Journal:  Schweiz Med Wochenschr       Date:  1985-06-15

7.  Chronic or fatal Q-fever infection: a review of 16 patients seen in North-East Scotland (1967-80).

Authors:  M E Ellis; C C Smith; M A Moffat
Journal:  Q J Med       Date:  1983

8.  Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis.

Authors:  M G Peacock; R N Philip; J C Williams; R S Faulkner
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

Authors:  M R Yeaman; L A Mitscher; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

10.  Endocarditis due to Q fever in Nova Scotia: experience with five patients in 1981-1982.

Authors:  E V Haldane; T J Marrie; R S Faulkner; S H Lee; J H Cooper; D D MacPherson; T J Montague
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226
View more
  33 in total

1.  Culture-negative endocarditis: "whatever remains, however improbable, must be the truth"; the importance of asking the right questions!

Authors:  Amar Bhavin Kachhia; Douglas Wan; Andrew Whittaker; Naeem Shaukat; Salman S Nishtar; James Cullen
Journal:  BMJ Case Rep       Date:  2009-09-20

2.  Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection.

Authors:  Laura Buttrum; Lindsey Ledbetter; Rama Cherla; Yan Zhang; William J Mitchell; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

Review 3.  Chronic Q fever in the United States.

Authors:  Petros C Karakousis; Michele Trucksis; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.

Authors:  Guoquan Zhang; Ho To; Kasi E Russell; Laura R Hendrix; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai; James E Samuel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Late relapse of Q fever endocarditis.

Authors:  Andreas J Morguet; Andreas Jansen; Didier Raoult; Thomas Schneider
Journal:  Clin Res Cardiol       Date:  2007-04-26       Impact factor: 5.460

Review 6.  Diagnosis of Q fever.

Authors:  P E Fournier; T J Marrie; D Raoult
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

7.  Acute Q fever in Portugal. Epidemiological and clinical features of 32 hospitalized patients.

Authors:  Carolina Palmela; Robert Badura; Emília Valadas
Journal:  Germs       Date:  2012-06-01

8.  In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; E Scoulica; A Psaroulaki; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

9.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

10.  Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii.

Authors:  D Musso; M Drancourt; S Osscini; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.